当前位置：
X-MOL 学术
›
ACS Med. Chem. Lett.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Selective Estrogen Receptor Degraders for the Potential Treatment of Cancer.
ACS Medicinal Chemistry Letters ( IF 4.2 ) Pub Date : 2020-03-09 , DOI: 10.1021/acsmedchemlett.0c00107 Robert B Kargbo 1
Dobovisek, L.; Borstnar, S.; Krstanovic, F.; Debeljak, N. Cancers 2020, 12, 525. Liu, W.; Zhao, G.; Zhang, C.; Yang, C.; Zeng, X.; Li, J.; Zhu, K.; Zhao, S.; Lu, H.; Yin, D. J. Cell. Biochem. 2020, 121, 2756. Bimonte, S.; Cascella, M.; Barbieri, A.; Arra, C.; Cuomo, A. Infect. Agent Cancer 2020, 15, 2. Jeong, S.; Park, M.; Song, W.; Kim, H. Clin. Biochem. 2020, ASAP: https://www.sciencedirect.com/science/article/pii/S0009912019310562?via%3Dihub. Pepermans, R. A.; Prossnitz, E. Steroids. 2019, 153, 108493. The author declares no competing financial interest. This article has not yet been cited by other publications.
更新日期：2020-04-23
ACS Medicinal Chemistry Letters ( IF 4.2 ) Pub Date : 2020-03-09 , DOI: 10.1021/acsmedchemlett.0c00107 Robert B Kargbo 1
Affiliation
京公网安备 11010802027423号